Indeed, recent research has established that BC cases with high AR levels relative to ER or PgR (i.e. AR/ER ≥ 2 and AR/PgR ≥ 1.54, respectively) are associated with aggressive clinical and biological features, poor prognosis20–23 and resistance to therapy24. Here, ESR1 is linked to breast cancer.